Avenir Wellness Solutions (AVRW) AI Stock Analysis

• Market Cap: $591.94K
• Dividend Yield: N/A
• Average Volume (3M): 33.41K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.21
• Revenue Growth: -50.68%
• EPS Growth: 76.08%
• Country: US
• Employees: 11
• Sector: Healthcare
• Sector Strength: 38
• Industry: Packaged Foods
• EPS (TTM): -0.04
• Shares Outstanding: 78,925,170
• 10 Day Avg. Volume: 16,300
• 30 Day Avg. Volume: 33,406
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.06
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.46
• Enterprise Value/Market Cap: 16.15
• Enterprise Value/Revenue: 0.75
• Enterprise Value/Gross Profit: 6.67
• Enterprise Value/Ebitda: -0.67
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 36 Underperform
• Price Target: ―

Avenir Wellness Solutions faces significant financial challenges, with declining revenue, high leverage, and liquidity issues. The technical analysis shows lackluster momentum, and the negative P/E ratio suggests ongoing profitability concerns. No dividend yield further detracts from the stock's appeal. Overall, the stock's financial instability and lack of positive growth prospects result in a low score, underscoring the need for substantial strategic changes.

Avenir Wellness Solutions Business Overview & Revenue Model

Company Description

Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders, including opt-in subscriptions. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is headquartered in Sherman Oaks, California.

How the Company Makes Money

Avenir Wellness Solutions generates revenue primarily through the sale of its health supplements and personal care products. These products are distributed via both direct-to-consumer e-commerce platforms and partnerships with retail chains, providing a broad market reach. Additionally, the company monetizes its digital wellness solutions through subscription-based models, offering users personalized health insights and guidance. Strategic partnerships with research institutions and technology firms also play a role in enhancing product development and broadening market opportunities, contributing to the company's overall earnings.

Avenir Wellness Solutions Financial Statement Overview

Summary

Avenir Wellness Solutions is facing severe financial challenges across all key metrics. The income statement reveals a lack of revenue growth and profitability, while the balance sheet highlights excessive leverage and negative equity. Cash flow difficulties further compound the company's financial distress, with liquidity concerns and operational inefficiencies evident. The overall financial health of the company is precarious, requiring strategic restructuring to address these issues.

Income Statement

Avenir Wellness Solutions has been experiencing declining revenue over the years, with a significant decrease from 2021 to 2022 and continuing into 2023. The gross profit margin, though relatively high, is overshadowed by negative EBIT and net profit margins, indicating operational inefficiencies and substantial losses. The company has not demonstrated revenue growth, and profitability remains a major concern.

Balance Sheet

The balance sheet reveals a concerning financial structure with negative stockholders' equity, indicating insolvency. The debt-to-equity ratio is not calculable due to negative equity, but the high level of debt compared to assets suggests significant leverage and financial risk. The equity ratio is negative, further highlighting the weak financial stability of the company.

Cash Flow

Cash flow analysis shows consistent negative operating cash flow and free cash flow, reflecting ongoing financial strain. The operating cash flow to net income ratio is negative due to persistent losses, and the free cash flow growth rate is unfavorable. The cash flow situation indicates liquidity challenges and an inability to generate sufficient cash to cover expenses.

Breakdown	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	4.35M	4.90M	6.08M	2.05M	623.00K
Gross Profit	3.11M	3.34M	4.33M	975.00K	392.00K
EBITDA	-3.20M	-16.45M	-5.53M	-27.22M	-16.64M
Net Income	-3.44M	-25.51M	-13.19M	-30.62M	-21.36M
Balance Sheet
Total Assets	2.61M	6.85M	40.57M	46.36M	32.46M
Cash, Cash Equivalents and Short-Term Investments	49.00K	2.94M	16.00K	1.73M	4.10M
Total Debt	8.28M	10.06M	13.87M	16.33M	779.00K
Total Liabilities	12.49M	13.96M	24.46M	25.08M	16.13M
Stockholders Equity	-9.89M	-7.11M	16.11M	21.28M	13.51M
Cash Flow
Free Cash Flow	-3.90M	-10.07M	-4.43M	-10.41M	-8.51M
Operating Cash Flow	-3.84M	-10.07M	-4.32M	-9.72M	-8.10M
Investing Cash Flow	971.00K	13.84M	-175.00K	-131.00K	-917.00K
Financing Cash Flow	-22.00K	-837.00K	2.78M	7.48M	12.61M

Avenir Wellness Solutions Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVRW, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.01, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 42.00 is Neutral, neither overbought nor oversold. The STOCH value of 27.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVRW.

Avenir Wellness Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SENEA	78 Outperform	$721.48M	17.77	6.77%	―	8.25%	-30.16%
USNA	70 Outperform	$547.33M	16.31	6.54%	―	2.75%	-37.25%
STKL	55 Neutral	$685.27M	―	-5.95%	―	2.44%	91.41%
NAII	53 Neutral	$22.31M	―	-10.25%	―	-1.16%	-146.23%
Sector *	51 Neutral	$7.35B	0.50	-65.61%	2.47%	15.28%	1.44%
BRCC	50 Neutral	$407.08M	―	-49.54%	―	-6.69%	55.07%
AVRW	36 Underperform	$591.94K	―	21.97%	―	-50.68%	76.08%